After a weak FY24 guidance in Q4-23, KRSNAA gave a strong guidance for FY24 in Q1-24. Change shows the confidence the management has about its prospects & creates opportunities in the stock.
Share this post
Krsnaa Diagnostics: 30-35% revenue CAGR for…
Share this post
After a weak FY24 guidance in Q4-23, KRSNAA gave a strong guidance for FY24 in Q1-24. Change shows the confidence the management has about its prospects & creates opportunities in the stock.